SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

 X  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended November 30, 2002      File Number 0-288

Robbins & Myers, Inc.
(Exact name of registrant as specified in its charter)

Ohio	31-0424220
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1400 Kettering Tower, Dayton, Ohio	45423
(Address of Principal executive offices)	(Zip Code)

Registrant’s telephone number including area code (937) 222-2610

None

Former name, former address and former fiscal year if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. YES X NO    

Common shares, without par value, outstanding as of November 30, 2002: 14,350,310

1

TABLE OF CONTENTS

EXHIBIT 99.1 Section 906 Certification of CEO

EXHIBIT 99.2 Section 906 Certification of CFO

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEET
(In thousands)

				November 30,			August 31,
				2002			2002
				(Unaudited)
ASSETS
Current Assets
	Cash and cash equivalents			$	14,161		$	10,534
	Accounts receivable				107,222			113,711
	Inventories:
		Finished products			30,108			29,000
		Work in process			23,346			22,487
		Raw materials			42,524			40,959
					95,978			92,446
	Other current assets				11,684			12,318
	Deferred taxes				14,102			14,071
			Total Current Assets		243,147			243,080
Goodwill					280,339			271,948
Other Intangible Assets					17,529			17,604
Other Assets					6,793			6,201
Property, Plant and Equipment					268,490			261,926
	Less accumulated depreciation				(123,190	)		(118,067	)
					145,300			143,859
				$	693,108		$	682,692
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
	Accounts payable			$	41,274		$	41,964
	Accrued expenses				77,147			83,871
	Current portion of long-term debt				6,662			4,526
			Total Current Liabilities		125,083			130,631
Long-Term Debt-Less Current Portion					214,092			203,920
Deferred Taxes					8,905			8,708
Other Long-Term Liabilities					72,562			70,863
Minority Interest					8,173			8,347
Shareholders’ Equity
	Common stock				103,925			103,923
	Retained earnings				177,830			176,627
	Accumulated other comprehensive loss				(17,462	)		(20,057	)
					264,293			260,493
				$	693,108		$	682,692

See Notes to Consolidated Condensed Financial Statements

2

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED INCOME STATEMENT
(In thousands, except per share data)
(Unaudited)

		Three Months Ended
		November 30,
		2002		2001
Net sales		$	124,828	$	139,387
Cost of sales			83,280		92,443
Gross profit			41,548		46,944
SG&A expenses			33,966		33,761
Amortization expense			539		558
Income before interest and income taxes			7,043		12,625
Interest expense			3,858		4,053
Income before income taxes and minority interest			3,185		8,572
Income tax expense			1,067		2,872
Minority interest			128		259
Net income		$	1,990	$	5,441
Net income per share:
	Basic	$	0.14	$	0.46
	Diluted	$	0.14	$	0.43
Dividends per share:
	Declared	$	0.055	$	0.055
	Paid	$	0.055	$	0.055

See Notes to Consolidated Condensed Financial Statements

3

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS
(In thousands)
(Unaudited)

				Three Months Ended
				November 30,
				2002			2001
Operating Activities:
	Net income			$	1,990		$	5,441
	Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
		Depreciation			5,049			5,390
		Amortization			539			558
		Performance stock awards			0			63
		Changes in operating assets and liabilities:
			Accounts receivable		7,978			915
			Inventories		(2,292	)		(1,752	)
			Accounts payable		(1,096	)		1,631
			Accrued expenses		(5,925	)		(6,348	)
			Other		1,127			(2,700	)
Net Cash and Cash Equivalents Provided by Operating Activities					7,370			3,198
Investing Activities:
	Capital expenditures, net of nominal disposals				(2,913	)		(2,802	)
	Purchase of Tarby				(11,926	)		0
	Romaco acquisition costs				0			(2,596	)
Net Cash and Cash Equivalents Used by Investing Activities					(14,839	)		(5,398	)
Financing Activities:
	Proceeds from debt borrowings				28,099			29,173
	Payments of long-term debt				(16,216	)		(31,787	)
	Proceeds from sale of common stock				0			1,436
	Dividends paid				(787	)		(647	)
Net Cash and Cash Equivalents Provided (Used) by Financing Activities					11,096			(1,825	)
Increase (Decrease) in Cash and Cash Equivalents					3,627			(4,025	)
Cash and Cash Equivalents at Beginning of Period					10,534			16,122
Cash and Cash Equivalents at End of Period				$	14,161		$	12,097

See Notes to Consolidated Condensed Financial Statements

4

ROBBINS & MYERS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
November 30, 2002
(Unaudited)

NOTE 1 — Preparation of Financial Statements
In the opinion of management, the accompanying unaudited consolidated condensed financial statements of Robbins & Myers, Inc. and subsidiaries (“we,” “our”) contain all adjustments, consisting of normally recurring items, necessary to present fairly our financial condition as of November 30, 2002, and August 31, 2002, and the results of our operations and cash flows for the three month periods ended November 30, 2002 and 2001. All intercompany transactions have been eliminated. Certain amounts in the prior period financial statements have been reclassified to conform to the current year presentation.

NOTE 2 — Acquisition
On November 15, 2002, we purchased the stock of Tarby, Inc. (“Tarby”) for $11,926,000. Tarby is a manufacturer and marketer of progressing cavity pumps and components for the general industrial and municipal wastewater markets with annual sales of approximately $6,000,000.

NOTE 3 — Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the three month period ended November 30, 2002, by operating segment, are as follows:

	Pharmaceutical		Energy			Industrial
	Segment		Segment			Segment			Total
	(In thousands)
Balance as of September 1, 2002	$	161,138	$	68,098		$	42,712		$	271,948
Goodwill acquired during the period		0		0			7,866			7,866
Translation adjustments and other		636		(43	)		(68	)		525
Balance as of November 30, 2002	$	161,774	$	68,055		$	50,510		$	280,339

Information regarding our other intangible assets is as follows:

	As of November 30, 2002						As of August 31, 2002
	Carrying		Accumulated				Carrying		Accumulated
	Amount		Amortization		Net		Amount		Amortization		Net
					(In thousands)
Patents and Trademarks	$	7,260	$	1,276	$	5,984	$	7,260	$	1,103	$	6,157
Non-compete Agreements		10,752		7,949		2,803		10,752		7,823		2,929
Financing Costs		7,092		3,583		3,509		6,668		3,363		3,305
Pension Intangible		4,564		0		4,564		4,564		0		4,564
Other		2,078		1,409		669		2,038		1,389		649
Total	$	31,746	$	14,217	$	17,529	$	31,282	$	13,678	$	17,604

5

NOTE 4 — Net Income per Share

				Three Months Ended
				November 30,
				2002		2001
				(In thousands, except per share
				amounts)
Numerator:
	Basic:
		Net income		$	1,990	$	5,441
		Effect of dilutive securities:
			Convertible debt interest		582		582
	Income attributable to diluted shares			$	2,572	$	6,023
Denominator:
	Basic:
		Weighted average shares			14,344		11,773
		Effect of dilutive securities:
			Convertible debt		2,191		2,191
			Dilutive options and restricted shares		33		156
	Diluted shares				16,568		14,120
Basic net income per share				$	0.14	$	0.46
Diluted net income per share — reported (a)				$	0.14	$	0.43
Diluted net income per share — computed (a)				$	0.16	$	0.43

(a)  For the three month period ended November 30, 2002, the computed diluted net income per share is $0.16. However, diluted net income per share may not exceed basic net income per share. Therefore, the reported diluted net income per share is $0.14.

NOTE 5 — Long-Term Debt

		November 30, 2002
		(In thousands)
Senior debt:
	Revolving credit loan	$	20,997
	Senior notes		100,000
	Other		19,630
10.00% subordinated notes			20,436
6.50% Convertible subordinated notes			59,691
Total debt			220,754
Less current portion			6,662
		$	214,092

Our Bank Credit Agreement (“Agreement”) provides that we may borrow on a revolving credit basis up to a maximum of $126,123,000. All outstanding amounts under the Agreement are due and payable on January 9, 2005. Interest is variable based upon formulas tied to LIBOR or prime, at our option, and is payable at least quarterly. At November 30, 2002, the weighted average interest rate for all amounts outstanding was 4.07%. Indebtedness under the Agreement is unsecured, except for guarantees by our U.S. subsidiaries, the pledge of the stock of our U.S. subsidiaries and the pledge of the stock of certain non-U.S. subsidiaries.

We have $100,000,000 of Senior Notes (“Senior Notes”) issued in two series. Series A in the principal amount of $70,000,000 has an interest rate of 6.76% and is due May 1, 2008, and Series B in the principal amount of $30,000,000 has an interest rate of 6.84% and is due May 1, 2010. Interest is payable semi-annually on May 1 and November 1.

6

The above agreements have certain restrictive covenants including limitations on cash dividends, treasury stock purchases and capital expenditures, and minimum requirements for interest coverage and leverage ratios. The amount of cash dividends and treasury stock purchases, other than in relation to stock option exercises, we may incur in each fiscal year is restricted to the greater of $3,500,000 or 50% of our consolidated net income for the immediately preceding fiscal year, plus a portion of any unused amounts from the preceding fiscal year. Under this Agreement and other lines of credit, we could incur additional indebtedness of approximately $25,000,000 based on our covenant position.

Our other debt primarily consists of unsecured non-U.S. bank lines of credit with interest rates ranging from 4.00% to 8.00%.

We have $20,436,000 of 10.00% Subordinated Notes (“Subordinated Notes”) with the former owner of Romaco. The Subordinated Notes are due in 2006 and 2007 and interest is payable quarterly.

We have $59,691,000 of 6.50% Convertible Subordinated Notes Due 2003 (“Convertible Subordinated Notes”). The Convertible Subordinated Notes are due on September 1, 2003, and bear interest at 6.50%, payable semi-annually on March 1 and September 1 and are convertible into common stock at a rate of $27.25 per share. Holders may convert at any time until maturity and we may call for redemption at any time until maturity at par.

Subsequent to November 30, 2002, we made an offer to the current holders of the Convertible Subordinated Notes to exchange up to $40,000,000 of the Convertible Subordinated Notes for new Convertible Subordinated Notes that bear interest at 8.00%, are due on January 31, 2008, and are convertible into common stock at a rate of $22.50 per share.

The Convertible Subordinated Notes and the Subordinated Notes are subordinated to all of our other indebtedness.

We have entered into an interest rate swap agreement. The interest rate swap agreement utilized by us effectively modifies our exposure to interest rate risk by converting our fixed rate debt to floating rate debt. This agreement involves the receipt of fixed rate amounts in exchange for floating rate interest payments over the life of the agreement without an exchange of underlying principal amounts. The fair value hedge qualifies for treatment under the short cut method of measuring effectiveness. As a result, there is no impact on earnings due to hedge ineffectiveness. The interest rate swap agreement totals $30,000,000, expires in 2008 and allows us to receive an interest rate of 6.76% and pay an interest rate based on LIBOR.

NOTE 6 — Income Taxes
The estimated annual effective tax rate was 33.5% for the three month periods ended November 30, 2002 and 2001.

7

NOTE 7 — Comprehensive Income

		Three Months Ended
		November 30,
		2002		2001
		(In thousands)
Net income		$	1,990	$	5,441
Other comprehensive income:
	Foreign currency translation		2,610		(2,246	)
Comprehensive income		$	4,600	$	3,195

NOTE 8 — Business Segments
Sales and Income before Interest and Taxes (“EBIT”) by operating segment is presented in the following table.

		Three Months Ended
		November 30,
		2002			2001
		(In thousands)
Unaffiliated customer sales:
	Pharmaceutical	$	74,946		$	83,205
	Industrial		27,843			32,443
	Energy		22,039			23,739
	Total	$	124,828		$	139,387
EBIT:
	Pharmaceutical	$	3,722		$	8,197
	Industrial		1,816			2,270
	Energy		4,513			4,812
	Corporate and eliminations		(3,008	)		(2,654	)
	Total	$	7,043		$	12,625

8

Part I—Management’s Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations

     The following tables present the components of our consolidated income statement and segment information for the first three month periods of fiscal 2003 and 2002.

	Three Months Ended
	November 30,
	2002			2001
Net sales		100.0	%		100.0	%
Cost of sales		66.7			66.3
Gross profit		33.3			33.7
SG&A expenses		27.2			24.2
Amortization		0.5			0.4
EBIT		5.6	%		9.1	%

			Three Months Ended
			November 30,
			2002			2001
			(In thousands)
Segment
	Pharmaceutical:
		Sales	$	74,946		$	83,205
		EBIT		3,722			8,197
		EBIT%		5.0	%		9.9	%
	Industrial:
		Sales	$	27,843		$	32,443
		EBIT		1,816			2,270
		EBIT%		6.5	%		7.0	%
	Energy:
		Sales	$	22,039		$	23,739
		EBIT		4,513			4,812
		EBIT%		20.5	%		20.3	%

Three months ended November 30, 2002

     Net sales for the first quarter of fiscal 2003 were $124.8 million compared with $139.4 million in the first quarter of fiscal 2002.

     The Pharmaceutical segment had sales of $74.9 million in the first quarter of fiscal 2003 compared with $83.2 million in the first quarter of fiscal 2002. The change in exchange rates, primarily the strengthening of the Euro, increased the first quarter of fiscal 2003 sales by $5.1 million compared with the first quarter of fiscal 2002. The sales decline was due to the weak specialty chemical market and slow industrial economy in the U.S. Orders for this segment increased from $74.4 million in the first quarter of fiscal 2002 to $75.0 million in the first quarter of fiscal 2003. Backlog in this segment was $100.7 million at the end of the first quarter of fiscal 2003 compared with $100.8 million at August 31, 2002.

     The Industrial segment had sales of $27.8 million in the first quarter of fiscal 2003 compared with $32.4 million in the first quarter of fiscal 2002. The decline in sales was across all of our businesses in this segment and was again due to the weak specialty chemical market as well as the slow industrial economy in the U.S. Incoming orders in this segment were $30.5 million in the first quarter of fiscal 2003 compared with $27.5 million in the first quarter of fiscal 2002. Backlog in this segment increased to $24.0 million at the end of the first quarter of fiscal 2003 from $21.6 million at August 31, 2002.

9

     The Energy segment had sales of $22.0 million in the first quarter of fiscal 2003 compared with $23.7 million in the first quarter of fiscal 2002, a decrease of $1.7 million or 7.2%. Crude oil and natural gas drilling activity remain at cyclical lows due to the current inventory levels. Incoming orders in this segment were $22.2 million in the first quarter of fiscal 2003, compared with $21.9 million in the first quarter of fiscal 2002. Backlog increased to $3.5 million at the end of the first quarter of fiscal 2003 from $3.3 million at August 31, 2002.

     EBIT for the first quarter of fiscal 2003 was $7.0 million compared with $12.6 million in the first quarter of fiscal 2002.

     The Pharmaceutical segment had EBIT of $3.7 million in the first quarter of fiscal 2003 compared with $8.2 million in the first quarter of fiscal 2002. The decrease in EBIT was due to lower sales volumes and lower prices in our Reactor Systems’ European operations.

     The Industrial segment had EBIT of $1.8 million in the first quarter of fiscal 2003 compared with $2.3 million in the first quarter of fiscal 2002, a reduction of $0.5 million. We have reduced our operating expenses in this segment and therefore the reduction in EBIT is only $0.5 million on a sales decline of $4.6 million.

     The Energy segment had EBIT of $4.5 million in the first quarter of fiscal 2003 compared with $4.8 million in the first quarter of fiscal 2002, a decrease of $0.3 million or 6.3%. The aforementioned decline in Energy segment sales caused the reduction in EBIT.

     Interest expense decreased from $4.1 million in the first quarter of fiscal 2002 to $3.9 million in the first quarter of fiscal 2003. This was due primarily to lower average debt levels.

     The effective tax rate was 33.5% in fiscal 2003 and fiscal 2002.

     The overall decline in net income and diluted net income per share in the first quarter of fiscal 2003 was due to lower EBIT as a result of lower sales volumes.

10

Liquidity and Capital Resources

     Cash uses in the first three months of fiscal 2003 were $5.1 million in semi-annual interest payments due on our Senior Notes and Convertible Subordinated Notes, $0.5 million for variable pay plans (both included in accrued expenses), $2.9 million for capital expenditures and $11.9 million for the purchase of Tarby. Cash generated from operations and borrowings under our revolving line of credit funded these cash uses.

     Cash uses in the first three months of fiscal 2002 were $5.3 million in semi-annual interest payments due on our Senior Notes and Convertible Subordinated Notes, $2.8 for variable pay plans, $2.0 million in income tax payments (all included in accrued expenses), $2.8 million for capital expenditures, and $2.6 million in acquisition costs related to the Romaco acquisition. Cash generated from operations funded these cash uses.

     We expect operating cash flow to be adequate for the remainder of fiscal year 2003 operating needs, scheduled debt service and shareholder dividend requirements. The major cash requirement for the remainder of fiscal 2003 is planned capital expenditures of approximately $12.0 million. Capital expenditures are related to additional production capacity, cost reductions and replacement items.

     We have $59.7 million of Convertible Subordinated Notes that are due on September 1, 2003 (fiscal year 2004). We have made an offer to the current holders of the Convertible Subordinated Notes to exchange up to $40.0 million of these notes for new convertible subordinated notes. For any Convertible Subordinated Notes not exchanged, we can use capacity under our Bank Credit Agreement to repay these notes, because utilizing borrowings under our Bank Credit Agreement would not create additional debt and therefore not impact our position with regard to debt covenants.

Market Risk

     In its normal operations we have market risk exposure to foreign currency exchange rates and interest rates. During fiscal 2003 there has been no significant change in our exposure to these risks.

Forward-looking Statements

     In addition to historical information, this report contains forward-looking statements identified by use of words such as “expects,” “anticipates,” “estimates,” and similar expressions. These statements reflect our expectations at the time this report was issued. Actual events and results may differ materially from those described in the forward-looking statements. Among the factors that could cause material differences are significant changes in capital expenditures in the specialty chemical and pharmaceutical industries, a major change in oil and natural gas prices, foreign exchange rate fluctuations, continued availability of acceptable acquisition candidates, access to capital and financing and general economic conditions that can affect demand in the process industries. We undertake no obligation to update or revise any forward-looking statement.

11

Item 4. Controls And Procedures

(a)

Based on a recent evaluation, which was performed within 90 days of the filing of this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-14 and 15d-14) are effective in timely alerting them to material information relating to us (including our consolidated subsidiaries) required to be included in periodic reports filed under the Securities Exchange Act.

(b)

There have been no significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to November 30, 2002.

12

Part II—Other Information

Item 6. Exhibits and Reports on Form 8-K

a)	Exhibits – see INDEX TO EXHIBITS
b)	Reports on Form 8-K. During the quarter ended November 30, 2002, we filed an 8-K on October 2, 2002 to announce an amendment to the terms of our revolving credit agreement.

13

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			ROBBINS & MYERS, INC.
DATE:	January 8, 2003	BY	/s/ Kevin J. Brown Kevin J. Brown Vice President and Chief Financial Officer (Principal Financial Officer)
DATE:	January 8, 2003	BY	/s/ Thomas J. Schockman Thomas J. Schockman Corporate Controller (Principal Accounting Officer)

14

CERTIFICATIONS

I, Gerald L. Connelly, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Robbins & Myers, Inc. (the “Registrant”).
2.	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstance under such statements were made, not misleading with respect to the period covered by this quarterly report;
3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this quarterly report;
4.	The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant and have:

a)	designed such disclosure controls and procedures to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)	evaluated the effectiveness of the Registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
c)	presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a)	all significant deficiencies in the design or operation of internal controls which could adversely affect the Registrant’s ability to record, process, summarize and report financial data and have identified for the Registrant’s auditors any material weaknesses in internal controls; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal controls; and

6. The Registrant’s other certifying officer and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date:	January 8, 2003
		/s/ Gerald L. Connelly Gerald L. Connelly President and Chief Executive Officer

15

CERTIFICATIONS

I, Kevin J. Brown, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Robbins & Myers, Inc. (the “Registrant”).
2.	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstance under such statements were made, not misleading with respect to the period covered by this quarterly report;
3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this quarterly report;
4.	The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant and have:

a)	designed such disclosure controls and procedures to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)	evaluated the effectiveness of the Registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
c)	presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

d)	all significant deficiencies in the design or operation of internal controls which could adversely affect the Registrant’s ability to record, process, summarize and report financial data and have identified for the Registrant’s auditors any material weaknesses in internal controls; and
e)	any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal controls; and

6. The Registrant’s other certifying officer and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date:	January 8, 2003
		/s/ Kevin J. Brown Kevin J. Brown Vice President and Chief Financial Officer

16

INDEX TO EXHIBITS

(99)  OTHER EXHIBITS

99.1	Certification of Chief Executive Officer of Robbins & Myers, Inc. in accordance with Section 906 of the Sarbanes-Oxley Act of 2002
99.2	Certification of Chief Financial Officer of Robbins & Myers, Inc. in accordance with Section 906 of the Sarbanes-Oxley Act of 2002

17